EndoRel Biosciences
- Biotech or pharma, therapeutic R&D
EndoRel Biosciences, an early-stage biotech company in Portland, Oregon, has developed a novel peptide-based endosomal release technology to provide robust cytosolic delivery for RNA therapeutics and other biomacromolecules. Our initial focus is the integration of our endosomal release peptide with Antibody-Drug Conjugates intended for intracellular targets.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}